NICE Guidance by month - September 2014

Reference Guidance Programme Topic
PHG In development  Exercise referral schemes
Guidelines
Physical activity
CG In development  Bipolar disorder (update)
Guidelines
Bipolar disorder
CG In development  Long acting reversible contraception (update SC)
Guidelines
Contraception
PHG In development  Multimorbidities: system integration to meet population needs (topic deferred until further notice)
Guidelines
Multimorbidities
QSD In development  Acute coronary syndromes (including myocardial infarction)
Quality standards
Acute coronary syndromes
CG In development  Drug allergy
Guidelines
Medicines management: general and other
CG In development  Dyspepsia/GORD
Guidelines
Digestive tract conditions: general and other
TAG In development  Prostate cancer (hormone relapsed, bone metastases) - radium-223 dichloride [ID576]
Technology appraisals
Prostate cancer
TAG In development  Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib [ID605]
Technology appraisals
Skin cancer
DT In development  Self-monitoring coagulation status in people on long-term vitamin K antagonist therapy who have atrial fibrillation or heart valve disease: point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor)
Diagnostics guidance
Structural heart defects
QSD In development  Nocturnal enuresis in children and young people
Quality standards
Urinary incontinence
TAG In development  Prostate cancer (metastatic, hormone relapsed, not treated with chemotherapy) - abiraterone acetate (with prednisolone) [ID503]
Technology appraisals
Prostate cancer
TAG In development  Pancreatic cancer (locally advanced, metastatic) - masitinib [ID566]
Technology appraisals
Pancreatic cancer
QSD In development  Inflammatory bowel disease
Quality standards
Inflammatory bowel disease
CG In development  Acute heart failure
Guidelines
Heart failure
Get involved